Literature DB >> 30167935

The prognostic value of health-related quality of life in patients with Chagas heart disease.

Henrique Silveira Costa1, Márcia Maria Oliveira Lima2, Pedro Henrique Scheidt Figueiredo2, Ana Thereza Chaves3, Maria Carmo Pereira Nunes3, Manoel Otávio da Costa Rocha3.   

Abstract

PURPOSE: To verify the prognostic value of health-related quality of life (HRQoL) and the differences in HRQoL and clinical variables between groups of Chagas heart disease (CHD) patients with and without cardiovascular adverse events.
METHODS: Seventy-five CHD patients were evaluated by echocardiography, maximal exercise testing, and Short-form of Health Survey (SF-36) Questionnaire. Patients were followed during 6 years. In the statistical analysis, uni- and multivariate Cox regression were performed to verify the accuracy of the HRQoL in predicting cardiovascular events.
RESULTS: After the follow-up period (41 ± 12 months), 20 patients (27%) had adverse events. Those with poor outcome had lower left ventricular ejection fraction (LVEF) (p = 0.002), higher left ventricular end-diastolic diameter (LVDd) (p = 0.019), and worse scores in general health perceptions (p = 0.047), social role functioning (p = 0.026), and mental component summary (p = 0.043) of SF-36. Patients with lower LVEF (p = 0.003), higher LVDd (p = 0.022), worse HRQoL in the general heath perceptions domain (p = 0.022), and mental component summary (p = 0.031) were associated with worse prognosis. In the multivariate Cox regression, LVEF (HR 0.94, 95% CI from 0.90 to 0.98, p = 0.007) and mental component summary (HR 0.98, 95% CI from 0.94 to 1.00, p = 0.047) remained as independent predictors of adverse events in CHD patients.
CONCLUSION: The assessment of HRQoL, especially the mental component, should be taken into account to provide an accurate prognosis in addition to other well-established predictors of poor outcomes in CHD patients.

Entities:  

Keywords:  Chagas disease; Chagas heart disease; Health-related quality of life; Prognosis

Mesh:

Year:  2018        PMID: 30167935     DOI: 10.1007/s11136-018-1980-7

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  24 in total

Review 1.  An update on the management of Chagas cardiomyopathy.

Authors:  Manoel O C Rocha; Mauro M Teixeira; Antonio L Ribeiro
Journal:  Expert Rev Anti Infect Ther       Date:  2007-08       Impact factor: 5.091

2.  [Brazilian Consensus on Chagas Disease, 2015].

Authors:  João Carlos Pinto Dias; Alberto Novaes Ramos; Eliane Dias Gontijo; Alejandro Luquetti; Maria Aparecida Shikanai-Yasuda; José Rodrigues Coura; Rosália Morais Torres; José Renan da Cunha Melo; Eros Antonio de Almeida; Wilson de Oliveira; Antônio Carlos Silveira; Joffre Marcondes de Rezende; Fabiane Scalabrini Pinto; Antonio Walter Ferreira; Anis Rassi; Abílio Augusto Fragata; Andréa Silvestre de Sousa; Dalmo Correia; Ana Maria Jansen; Glaucia Manzan Queiroz Andrade; Constança Felícia De Paoli de Carvalho Britto; Ana Yecê das Neves Pinto; Anis Rassi; Dayse Elisabeth Campos; Fernando Abad-Franch; Silvana Eloi Santos; Egler Chiari; Alejandro Marcel Hasslocher-Moreno; Eliane Furtado Moreira; Divina Seila de Oliveira Marques; Eliane Lages Silva; José Antonio Marin-Neto; Lúcia Maria da Cunha Galvão; Sergio Salles Xavier; Sebastião Aldo da Silva Valente; Noêmia Barbosa Carvalho; Alessandra Viana Cardoso; Rafaella Albuquerque E Silva; Veruska Maia da Costa; Simone Monzani Vivaldini; Suelene Mamede Oliveira; Vera da Costa Valente; Mayara Maia Lima; Renato Vieira Alves
Journal:  Epidemiol Serv Saude       Date:  2016-06

3.  Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease.

Authors:  R A Bruce; F Kusumi; D Hosmer
Journal:  Am Heart J       Date:  1973-04       Impact factor: 4.749

4.  Heart-rate recovery immediately after exercise as a predictor of mortality.

Authors:  C R Cole; E H Blackstone; F J Pashkow; C E Snader; M S Lauer
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

5.  Health-related quality of life in patients with Chagas disease.

Authors:  Bruna Guimarães Oliveira; Mery Natali Silva Abreu; Claudia Drummond Guimarães Abreu; Manoel Otavio da Costa Rocha; Antonio Luiz Ribeiro
Journal:  Rev Soc Bras Med Trop       Date:  2011-03-18       Impact factor: 1.581

Review 6.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

7.  Summary health status measures in advanced heart failure: relationship to clinical variables and outcome.

Authors:  Mark D Sullivan; Wayne C Levy; Joan E Russo; Barbara Crane; John A Spertus
Journal:  J Card Fail       Date:  2007-09       Impact factor: 5.712

8.  Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial.

Authors:  Peter Carson; S William Tam; Jalal K Ghali; W Tad Archambault; Anne Taylor; Jay N Cohn; Virginia M Braman; Manuel Worcel; Inder S Anand
Journal:  J Card Fail       Date:  2009-12       Impact factor: 5.712

9.  Quality of life monitoring in ambulatory heart failure patients: temporal changes and prognostic value.

Authors:  Josep Lupón; Paloma Gastelurrutia; Marta de Antonio; Beatriz González; Lucía Cano; Roser Cabanes; Agustín Urrutia; Crisanto Díez; Ramón Coll; Salvador Altimir; Antoni Bayes-Genis
Journal:  Eur J Heart Fail       Date:  2012-08-23       Impact factor: 15.534

10.  Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure.

Authors:  Bożena Szyguła-Jurkiewicz; Michał Zakliczyński; Aleksander Owczarek; Robert Partyka; Mateusz Mościński; Robert Pudlo; Marcin Kaczmarczyk; Marian Zembala; Lech Poloński
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-09-28
View more
  5 in total

1.  Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis.

Authors:  Sindhu Chadalawada; Anis Rassi; Omar Samara; Anthony Monzon; Deepika Gudapati; Lilian Vargas Barahona; Peter Hyson; Stefan Sillau; Luisa Mestroni; Matthew Taylor; Maria da Consolação Vieira Moreira; Kristen DeSanto; Nelson I Agudelo Higuita; Carlos Franco-Paredes; Andrés F Henao-Martínez
Journal:  ESC Heart Fail       Date:  2021-10-30

2.  The health-related quality of life in patients with Chagas disease: the state of the art.

Authors:  Igor Lucas Geraldo Izalino de Almeida; Luciano Fonseca Lemos de Oliveira; Pedro Henrique Scheidt Figueiredo; Rafael Dias de Brito Oliveira; Thayrine Rosa Damasceno; Whesley Tanor Silva; Lucas Frois Fernandes de Oliveira; Matheus Ribeiro Ávila; Vanessa Pereira Lima; Ana Thereza Chaves Lages; Mauro Felippe Felix Mediano; Manoel Otávio Costa Rocha; Henrique Silveira Costa
Journal:  Rev Soc Bras Med Trop       Date:  2022-03-14       Impact factor: 1.581

3.  The association of exercise test variables with long-term mortality in patients with chronic Chagas disease.

Authors:  Rudson S Silva; Fernanda S N S Mendes; Jerome L Fleg; Luiz F Rodrigues Junior; Marcelo C Vieira; Isis G G Xavier; Henrique S Costa; Michel S Reis; Flavia Mazzoli-Rocha; Andrea R Costa; Marcelo T Holanda; Henrique H Veloso; Gilberto M Sperandio da Silva; Andréa S Sousa; Roberto M Saraiva; Alejandro Marcel Hasslocher-Moreno; Mauro F F Mediano
Journal:  Front Med (Lausanne)       Date:  2022-09-20

Review 4.  Quality of life in patients with Chagas disease and the instrument used: an integrative review.

Authors:  Nayara Ragi Baldoni; Nayara Dornela Quintino; Geisa Cristina Silva Alves; Claudia Di Lorenzo Oliveira; Ester Cerdeira Sabino; Antonio Luiz Pinho Ribeiro; Clareci Silva Cardoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-06-18       Impact factor: 2.169

5.  Prevalence and determinants of depressive symptoms in patients with Chagas cardiomyopathy and predominantly preserved cardiac function.

Authors:  Whesley Tanor Silva; Matheus Ribeiro Ávila; Lucas Frois Fernandes de Oliveira; Pedro Henrique Scheidt Figueiredo; Vanessa Pereira Lima; Alessandra de Carvalho Bastone; Fábio Silva Martins da Costa; Mauro Felippe Felix Mediano; Henrique Silveira Costa; Manoel Otávio da Costa Rocha
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-06       Impact factor: 1.581

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.